Two JAMA Surgery studies examine bariatric surgery for type 2 diabetes treatment

Roux-en-Y gastric bypass surgery resulted in the greatest average weight and appears to be the best treatment for type 2 diabetes mellitus (T2DM) compared to gastric banding and lifestyle intervention in a clinical trial that also highlights the challenges to completing a larger trial with patients with a body mass index (BMI) of 30 to 40.

Questions remain unanswered about the role of bariatric surgery in the treatment of T2DM, including the safety, efficacy and economic impact. Answers could come in a large, multicenter randomized clinical trial (RCT), but such a trial would be costly and potentially difficult to execute.

The authors report the results of an RCT examining the feasibility of a larger study and comparing the effectiveness of two types of bariatric surgery Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable (LAGB) and an intensive lifestyle weight-loss intervention in adults with a BMI of 30 to 40 and T2DM. While 667 adults were assessed for eligibility, the trial included 69 participants (24 assigned to receive RYGB, 22 to LAGB and 23 to the ).

Patients who had RYGB had the greatest weight change (-27 percent) compared with LAGB and the lifestyle intervention (-17.3 percent and -10.2 percent, respectively). No participants in the lifestyle intervention achieved partial or complete remission of T2DM at 12 months; 50 percent of the patients in the RYGB group had partial remission and 17 percent achieved complete remission, compared with the LAGB group where 27 percent of patients had partial T2DM remission and 23 percent had complete remission.

"This study highlights several potential challenges to successfully completing a larger RCT for treatment of T2DM and obesity in patients with a BMI of 30 to 40, including the difficulties associated with recruiting and randomizing patients to surgical vs. nonsurgical interventions." Anita P. Courcoulas, M.D., M.P.H., of the University of Pittsburgh Medical Center, and colleagues write in their JAMA Surgery paper.

Roux-en-Y Gastric Bypass Means Greater Weight Loss, Other Improvements in Obese Patients

Obese patients type 2 diabetes (T2DM) who underwent Roux-en-Y (RYGB) surgery had greater weight loss and other sustained improvements compared with intensive medical/weight management of the disease in a clinical trial that further confirmed the feasibility of conducting a larger trial to compare bariatric surgery with other interventions.

Data support as a therapeutic strategy to manage T2DM.

Authors tested the feasibility of conducting a larger trial to determine the long-term effect of RYGB compared with intensive medical/weight management in ( 30 to 42) with T2DM. The trial analyzed data from 38 participants (19 in the RYGB group and 19 in the medical/weight management intervention).

At one year, more patients in the RYGB group than the medical/weight management group (58 percent vs. 16 percent, respectively) achieved HbA 1c below 6.5 percent and fasting glucose below 126 mg/dL. Other outcomes, including HbA 1c , weight, waist circumference, fat mass, lean mass, blood pressure and triglyceride levels, decreased more and high-density lipoprotein cholesterol increased more after RYGB than the nonsurgical intervention.

"These differences may help inform therapeutic decisions for diabetes and weight loss strategies in obese patients with type 2 diabetes until larger randomized are performed." says Florencia Halperin, M.D., of the Brigham and Women's Hospital, Boston, and colleagues in the same JAMA Surgery issue.

More information: JAMA Surgery. Published online June 4, 2014. DOI: 10.1001/jamasurg.2014.467
JAMA Surgery. Published online June 4, 2014. DOI: 10.1001/jamasurg.2014.514

add to favorites email to friend print save as pdf

Related Stories

Decrease in fat cell volume improves insulin sensitivity

May 13, 2014

(HealthDay)—For obese women, a reduction in fat cell volume after bariatric surgery is strongly associated with improvement in insulin sensitivity, with the peak incidence seen among older women, according ...

Gastric bypass surgery may help manage diabetes risk factors

Jun 04, 2013

Among mild to moderately obese patients with type 2 diabetes, adding gastric bypass surgery to lifestyle and medical management was associated with a greater likelihood of improved levels of metabolic risk factors such as ...

Recommended for you

Pre-op opioid use tied to higher post-op dependence

Dec 15, 2014

(HealthDay)—Greater preoperative opioid use predicts increased immediate postoperative opioid demand and decreased incidence of postoperative opioid independence among spine surgery patients, according ...

Microbial flora ID'd in patients undergoing rhinoplasty

Dec 14, 2014

(HealthDay)—For patients undergoing rhinoplasty, preoperative nasal culture can identify microbial flora that indicate risk of postoperative infection, according to research published online Dec. 11 in ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.